Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Resolve Therapeutics licenses agents for autoimmune disease from University of Washington

Nov. 15, 2010

Biovista and Pfizer partner to identify new indications for Pfizer drug candidates

Nov. 11, 2010

Biocartis and bioMerieux partner to develop molecular diagnostics

Nov. 9, 2010

Covance and sanofi-aventis enter 10-year strategic collaboration

Nov. 3, 2010

Compugen licenses MAb-based oncology target to Seattle Genetics

Nov. 3, 2010

GSK and Amicus to develop Amigal for Fabry's disease

Nov. 2, 2010

Acadia enters agreement with Biovail to regain rights to pimavanserin

Nov. 2, 2010

AstraZeneca and Daiichi Sankyo announce agreement to copromote Nexium in Japan

Nov. 2, 2010

Biotie and Roche to terminate research and option agreement for SSAO inhibitors

Oct. 29, 2010

Evotec licenses EVT-201 to Jingxin Pharma

Oct. 29, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...